REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study

Clinical trial NCT04611425 · COMPLETED

Trial details

NCT number: NCT04611425
Sponsor: Nantes University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Failure COVID-19 Trauma Stroke Sepsis Shock

Start date: 2020-11-30
Primary completion: 2020-12-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.